Disparities Among Liver Transplant Patients

NCT05981196 | Recruiting

• 1 other identifier: 22-008581
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Conditions

End Stage Liver DIsease

Keywords

Transplants; Transplantation; Healthcare Disparities; Minority Health; Communication

Outcome Measures

Primary Outcomes (2)

• Liver transplant waiting list

  Number of subjects listed on the liver transplant waiting list

  Approximately one year

• Organ transplantation

  Number of subject to receive an organ transplantation

  Approximately one year

Secondary Outcomes (3)

• Survival

  Approximately one year post-transplant, or until you are removed from the transplant list

• Graft survival at six months

  Six months post transplant

• Graft survival at one year

  One year post transplant

Other Outcomes (4)

• Mortality

  Approximately one year post-transplant, or until you are removed from the transplant list

• Hospital length of stay

  Approximately one year post-transplant, or until you are removed from the transplant list

• ICU length of stay

  Approximately one year post-transplant, or until you are removed from the transplant list

Study Arms (1)

Liver Transplant Patients

Subjects with end-stage liver disease and being referred for transplant evaluation will fill out questionnaires about their background, emotions, and behaviors.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects identified with end-stage liver receiving initial stage of transplant evaluation at Mayo Clinic Arizona.

You may qualify if:

• \- Patients with end-stage liver, kidney, or cardiac dysfunction.

You may not qualify if:

• Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic Arizona

Phoenix, Arizona, 85054, United States

RECRUITING

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

End Stage Liver Disease; Communication

Condition Hierarchy (Ancestors)

Liver Failure; Hepatic Insufficiency; Liver Diseases; Digestive System Diseases; Behavior

Study Officials

• Peter E. Frasco, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabrielle Montefiore

CONTACT

480-574-1288

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 1, 2023
• First Posted: August 8, 2023
• Study Start: November 15, 2023
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): July 1, 2026
• Last Updated: April 17, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)